Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantPHARMA TO MARKET PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, SOLUTION
SUBCUTANEOUS
Medical Information
L03AA13
pegfilgrastim
Manufacturer Information
PHARMA TO MARKET PTE. LTD.
Biocon Biologics India Limited
Active Ingredients
Documents
Package Inserts
1.4.3 NUFILONG LEAFLET SINGAPORE_NEW_revised Nov 2021.pdf
Approved: December 8, 2021